Winston Pharmaceuticals, Inc.
WPHM
$0.00
$0.000.00%
OTC PK
| 03/31/2010 | 12/31/2009 | 09/30/2009 | 06/30/2009 | 03/31/2009 | |
|---|---|---|---|---|---|
| Net Income | 49.08% | 48.36% | 37.68% | 18.40% | -- |
| Total Depreciation and Amortization | -3.30% | 3.45% | 19.23% | 50.00% | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -- | -- | -65.70% | -83.72% | -- |
| Change in Net Operating Assets | -209.12% | -179.51% | -100.70% | -42.84% | -- |
| Cash from Operations | -5.84% | -37.11% | 13.99% | 9.20% | -- |
| Capital Expenditure | 100.00% | 95.21% | 95.21% | 95.21% | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 41.18% | 152.94% | 100.00% | 100.00% | -- |
| Cash from Investing | 94.12% | 101.23% | 95.71% | 97.34% | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -37.95% | -- | 2.49% | -72.92% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -100.00% | -16.83% | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -100.00% | -- | -- |
| Cash from Financing | -98.80% | -96.82% | -98.61% | -13.85% | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -470.45% | -454.81% | -160.02% | -23.42% | -- |